Equibles does not estimate personal net worth.
Get an email with a short summary when cbdMD, Inc. publishes a filing, an earnings call transcript or a press release.
Get YCBD alertsT. Ronan Kennedy is recorded as Board Member at cbdMD, Inc. (YCBD) since March 30, 2026 and CEO and CFO at cbdMD, Inc. (YCBD) since March 29, 2024. cbdMD, Inc. reported in an 8-K filed November 28, 2025 that T. Ronan Kennedy was appointed Chief Executive Officer and Chief Financial Officer, effective November 28, 2025. cbdMD, Inc. reported in an 8-K filed December 23, 2024 that T. Ronan Kennedy was appointed director, effective December 19, 2024. cbdMD, Inc. reported in an 8-K filed April 2, 2024 that T. Ronan Kennedy was appointed Chief Executive Officer, effective March 29, 2024. Equibles holds 6 filed executive changes naming T. Ronan Kennedy; each is listed under recent activity with its source filing. cbdMD, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at cbdMD, Inc. includes Martin A (CEO), Martin A. Sumichrast (CEO and Board Member), R. Scott (CEO) and 7 others.
“On November 28, 2025, cbdMD, Inc., a North Carolina corporation (the “Company”) entered into an Executive Employment Agreement (the “Agreement”) with T. Ronan Kennedy, the Company’s Chief Executive Officer and Chief Financial Officer.”
“Effective December 19, 2024, cbdMD, Inc. (the "Company") expanded the size of its Board of Directors from four to five members and appointed T. Ronan Kennedy as a director to fill the vacancy.”
2026-03-30–present
2024-03-29–present
2024-03-29–present
2021-03-03–2023-03-01
YCBD
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CEO, CFO
2021-03-03–present
